WuXi reaches into Israel with a new office and a local partnership

Chinese CRO WuXi PharmaTech ($WX) has opened up shop in Israel, cutting the ribbon on a Tel Aviv outpost and aligning itself with a local investor to expand its presence in the country. The new office will allow the company to promote its drug and device development services amid the country's growing life sciences industry, WuXi said, and the CRO has partnered with Pontifax, a local healthcare venture firm, to invest in complementary startups. News

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.